- Home
- CELC vs JACK Comparison
CELC vs JACK Comparison
Compare CELC & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- JACK
- Stock Information
- Founded
- CELC 2011
- JACK 1951
- Country
- CELC United States
- JACK United States
- Employees
- CELC N/A
- JACK N/A
- Industry
- CELC Medical Specialities
- JACK Restaurants
- Sector
- CELC Health Care
- JACK Consumer Discretionary
- Exchange
- CELC Nasdaq
- JACK Nasdaq
- Market Cap
- CELC 440.0M
- JACK 364.4M
- IPO Year
- CELC 2017
- JACK 1987
- Fundamental
- Price
- CELC $57.43
- JACK $18.13
- Analyst Decision
- CELC Strong Buy
- JACK Hold
- Analyst Count
- CELC 5
- JACK 18
- Target Price
- CELC $53.60
- JACK $34.06
- AVG Volume (30 Days)
- CELC 906.9K
- JACK 1.3M
- Earning Date
- CELC 08-14-2025
- JACK 08-06-2025
- Dividend Yield
- CELC N/A
- JACK 4.82%
- EPS Growth
- CELC N/A
- JACK N/A
- EPS
- CELC N/A
- JACK N/A
- Revenue
- CELC N/A
- JACK $1,488,411,000.00
- Revenue This Year
- CELC N/A
- JACK N/A
- Revenue Next Year
- CELC N/A
- JACK N/A
- P/E Ratio
- CELC N/A
- JACK N/A
- Revenue Growth
- CELC N/A
- JACK N/A
- 52 Week Low
- CELC $7.58
- JACK $16.53
- 52 Week High
- CELC $63.06
- JACK $54.42
- Technical
- Relative Strength Index (RSI)
- CELC 64.38
- JACK 44.11
- Support Level
- CELC $50.44
- JACK $17.70
- Resistance Level
- CELC $63.06
- JACK $21.17
- Average True Range (ATR)
- CELC 3.17
- JACK 1.09
- MACD
- CELC -0.47
- JACK 0.04
- Stochastic Oscillator
- CELC 60.71
- JACK 18.83
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About JACK Jack In The Box Inc.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.